Vaccine
CSL’s flu vaccine scores FDA approval
May 24, 2016Manufacturing and Production, Research and Development, Sales and Marketing CSL, FDA, Vaccine, flu, four strain, four-strain, influenza, influenza a, influenza b, seqirus
Seqirus, a division of CSL, has announced that the US Food and Drug Administration (FDA) has approved Flucelvax Quadrivalent (influenza …
Pfizer presents positive results in meningococcal disease late-stage trials
May 13, 2016Research and Development Pfizer, Vaccine, late stage trials, meningococcal disease
Pfizer (NYSE: PFE) has announced results from two pivotal late-stage trials demonstrating the immunogenicity of Trumenba against invasive meningococcal B …
Takeda secures $38 million grant to develop affordable polio vaccine
May 10, 2016Manufacturing and Production, Research and Development Bill and Melinda Gates Foundation, Gates Foundation, Takeda, Vaccine, access, developing countries, grant, polio
Takeda Pharmaceuticals has received a $38 million grant from the Bill and Melinda Gates Foundation to develop a low-cost polio …
Sanofi’s dengue vaccine rolled out for world’s first public immunisation program
April 4, 2016Sales and Marketing Philippines, Sanofi, Vaccine, children, dengue, dengvaxia, immunisation, prevention, public health
Sanofi, along with its vaccines global business unit Sanofi Pasteur, has announced the beginning of the first public dengue immunisation …
Sanofi Pasteur launches Zika vaccine R&D
February 2, 2016Manufacturing and Production, Research and Development Sanofi Pasteur, Vaccine, Zika virus
Sanofi Pasteur, the vaccines division of French pharma giant Sanofi, says it has launched a vaccine research and development project …
Janssen and Bavarian Nordic to collaborate on HPV vaccine
December 23, 2015Research and Development Bavarian Nordic, HPV, Janssen, Vaccine, human papillomavirus, prime boost
Janssen has announced a new collaboration and license agreement with Bavarian Nordic to develop a vaccine for chronic Human Papillomavirus …
TSRI and Janssen close in on universal flu vaccine
August 25, 2015Manufacturing and Production Janssen, Vaccine, flu, immunology, universal flu vaccine
Scientists from Janssen and The Scripps Research Institute (TSRI) have found a way to induce antibodies to fight a wide …
Encouraging first results from trial of Merck’s Ebola vaccine
July 31, 2015Research and Development, Sales and Marketing Africa, EBV, Ebola, Ebola virus, Ebola virus disease, Vaccine, WHO, World Health Organisation, guinea, vaccination
The first trial of an experimental Ebola vaccine suggests it provides high protection against the disease as early as ten …
New malaria vaccine found effective in adults
May 8, 2015Research and Development, Sales and Marketing Oxford, Plasmodium falciparum, Vaccine, malaria
A new malaria vaccine has shown promise in early stage trials, reducing the risk of contracting the disease by two …
Merck Ebola vaccine safe and effective in latest trials
April 2, 2015Research and Development, Sales and Marketing Ebola, Merck, National Institutes of Health, VSV-ZEBOV, Vaccine, Walter Reed Army Institute of Research, newlink
Merck and NewLink’s experimental Ebola vaccine has been found to be safe and effective in a new trial in the …
Merck and NewLink Ebola vaccine trial begins
March 6, 2015Sales and Marketing Ebola, Merck, Vaccine, WHO, newlink, rVSV-EBOV
Merck and US-based biopharma firm NewLink Genetics’ investigational Ebola vaccine is being used in Phase III trials in West Africa. …
ZMapp trials start in Liberia
March 2, 2015Research and Development, Sales and Marketing Africa, Ebola, Mapp, Vaccine, liberia, zmapp
Clinical trials to test the safety and efficacy of the experimental Ebola vaccine ZMapp are underway in infected parts of …
Flu vaccine ineffective against this season’s strain
February 6, 2015Research and Development, Sales and Marketing A(H3N2, Public Health England, UK, Vaccine, WHO, flu, phe
This season’s flu vaccine has provided little protection against the main strain circulating in the UK according to a new …
Pharma firms pledge vaccine support for developing countries
January 27, 2015Manufacturing and Production, Research and Development, Sales and Marketing GAVI, GSK, Janssen, Médecins Sans Frontières, Pfizer, Vaccine
Several pharma firms have announced commitments to help Gavi, the global vaccine alliance, to increase immunisation of children in developing …
MSF hits out at ‘astronomical’ vaccine prices
January 20, 2015Research and Development, Sales and Marketing Doctors Without Borders, GSK, Médicines San Frontières, Pfizer, Vaccine, diphtheria, measles, pertussis, poliomyelitis, tetanus, tuberculosis
Pharma companies have been named and shamed in a report calling on manufacturers to lower the cost of childhood vaccines …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
